|
MechanismPeptidoglycan inhibitors [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1954 |
100 Clinical Results associated with OHKURA Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with OHKURA Pharmaceutical Co., Ltd.
Trans-rosery agent as a pediatric product
Author: Hishikawa, Yoshihiro
30 Nov 2019·Pharm Tech Japan
Development of dry jelly, a new aosage form of jellies for oral adrmnistration
Study of dry jelly as a formulation suitable for infants: study on the granulation process of dry jelly and evaluation of the physical properties of the resultant jellies
Author: Kakino, Yukari ; Hori, Subaru ; Hishikawa, Yoshihiro ; Tahara, Kohei ; Takeuchi, Hirofumi
100 Deals associated with OHKURA Pharmaceutical Co., Ltd.
100 Translational Medicine associated with OHKURA Pharmaceutical Co., Ltd.